4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001140361-17-033207
Options or other derivatives
- Chief Business Officer acquired 10,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schuchart Aaron · Chief Business Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-08-22 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +10,000 | 10,000 | D |
Loading xslF345X03/doc1.xml…